Article Details

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints | Placera

Retrieved on: 2024-03-19 20:09:01

Tags for this article:

Click the tags to see associated articles and topics

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints | Placera. View article details on hiswai:

Excerpt

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA) ...

Article found on: www.placera.se

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up